Aleksei Titov

913 total citations
13 papers, 368 citations indexed

About

Aleksei Titov is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Aleksei Titov has authored 13 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Aleksei Titov's work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Aleksei Titov is often cited by papers focused on CAR-T cell therapy research (7 papers), Virus-based gene therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Aleksei Titov collaborates with scholars based in Russia, United Kingdom and Czechia. Aleksei Titov's co-authors include Alexey Petukhov, Emil Bulatov, Regina Miftakhova, Aygul Valiullina, Ekaterina Zmievskaya, Albert A. Rizvanov, Irina Ganeeva, Mauro Piacentini, Surinder M. Soond and Andrey Zaritskey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Frontiers in Immunology.

In The Last Decade

Aleksei Titov

12 papers receiving 365 citations

Peers

Aleksei Titov

ONCOL

IMMUN

MB

GENET

BE

Laura Kummer Germany

Vania Baldan United Kingdom

Ruimin Hong China

Anthony Leonardi United States

Liufang Gu China

Houli Zhao China

Paul Castillo United States

Conor Gruber United States

Reyisa Bughda United Kingdom

Ronan Thibaut France

Laura Kummer Germany

Aleksei Titov

198 ×0.9

ONCOL

130 ×0.9

IMMUN

105 ×0.9

MB

46 ×0.7

GENET

88 ×1.4

BE

Citations per year, relative to Aleksei Titov Aleksei Titov (= 1×) peers Laura Kummer

Countries citing papers authored by Aleksei Titov

Since Specialization

Citations

This map shows the geographic impact of Aleksei Titov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksei Titov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksei Titov more than expected).

Fields of papers citing papers by Aleksei Titov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksei Titov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksei Titov. The network helps show where Aleksei Titov may publish in the future.

Co-authorship network of co-authors of Aleksei Titov

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksei Titov. A scholar is included among the top collaborators of Aleksei Titov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksei Titov. Aleksei Titov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Földvári, Zsófia, Margs S. Brennan, Aleksei Titov, Sten Eirik W. Jacobsen, & Johanna Olweus. (2025). Targeting the roots of myeloid malignancies with T cell receptors. Nature reviews. Cancer. 25(12). 965–985.

2.

Zornikova, Ksenia V., Ivan V. Zvyagin, Yana Serdyuk, et al.. (2024). Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein. Frontiers in Immunology. 15. 1369436–1369436. 5 indexed citations

3.

Shkurnikov, M. Yu., et al.. (2023). HLA-A*01:01 allele diminishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire. PeerJ. 11. e14707–e14707. 2 indexed citations

4.

Zornikova, Ksenia V., et al.. (2022). Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response. Communications Biology. 5(1). 1351–1351. 9 indexed citations

5.

Titov, Aleksei, Yaroslav Kaminskiy, Irina Ganeeva, et al.. (2022). Knowns and Unknowns about CAR-T Cell Dysfunction. Cancers. 14(4). 1078–1078. 38 indexed citations

6.

Minervina, Anastasia A., Ekaterina A. Komech, Aleksei Titov, et al.. (2021). Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection. eLife. 10. 72 indexed citations

7.

Titov, Aleksei, Ekaterina Zmievskaya, Irina Ganeeva, et al.. (2021). Adoptive Immunotherapy beyond CAR T-Cells. Cancers. 13(4). 743–743. 73 indexed citations

8.

Лапин, С. В., et al.. (2020). Secondary hemophagocytic syndrome in adult patients. Study of 91 patients. SHILAP Revista de lepidopterología. 15(4). 52–64. 2 indexed citations

9.

Titov, Aleksei, Aygul Valiullina, Ekaterina Zmievskaya, et al.. (2020). Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment. Cancers. 12(1). 125–125. 61 indexed citations

10.

Лапин, С. В., et al.. (2019). [The role of fraction analysis of ferritin in diagnostic of secondary hemophagocyte syndrome].. PubMed. 63(1). 21–27. 1 indexed citations

11.

Titov, Aleksei, et al.. (2018). Manufacturing of CD19 Specific CAR T-Cells and Evaluation of their Functional Activity in Vitro. Clinical oncohematology. 11(1). 1–9. 6 indexed citations

12.

Titov, Aleksei, Alexey Petukhov, Emil Bulatov, et al.. (2018). The biological basis and clinical symptoms of CAR-T therapy-associated toxicites. Cell Death and Disease. 9(9). 897–897. 85 indexed citations

13.

Деркач, К. В., et al.. (2015). Intranasal and Intramuscular Administration of Lysine-Palmitoylated Peptide 612–627 of Thyroid-Stimulating Hormone Receptor Increases the Level of Thyroid Hormones in Rats. International Journal of Peptide Research and Therapeutics. 21(3). 249–260. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact